Page last updated: 2024-08-21

deoxyuridine and pemetrexed

deoxyuridine has been researched along with pemetrexed in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clarke, SJ; Li, KM; Rivory, LP	1
Boellaard, R; Frings, V; Giovannetti, E; Herder, GJ; Hoekstra, OS; Honeywell, R; Peters, GJ; Smit, EF; Thunnissen, E; van der Veldt, AA	1
Gerson, SL; Pink, JJ; Qing, Y; Yan, Y	1

Trials

1 trial(s) available for deoxyuridine and pemetrexed

Article	Year
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules. British journal of cancer, 2007, Oct-22, Volume: 97, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Deoxyuridine; Dietary Supplements; Dose-Response Relationship, Drug; Female; Folic Acid; Glutamates; Guanine; Homocysteine; Humans; Lung Neoplasms; Male; Methylmalonic Acid; Middle Aged; Pemetrexed; Thymidine; Thymidylate Synthase; Vinblastine; Vinorelbine; Vitamin B 12	2007

Article

Year

Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.

British journal of cancer, 2007, Oct-22, Volume: 97, Issue:8

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma, Non-Small-Cell Lung; Deoxyuridine; Dietary Supplements; Dose-Response Relationship, Drug; Female; Folic Acid; Glutamates; Guanine; Homocysteine; Humans; Lung Neoplasms; Male; Methylmalonic Acid; Middle Aged; Pemetrexed; Thymidine; Thymidylate Synthase; Vinblastine; Vinorelbine; Vitamin B 12

2007

Other Studies

2 other study(ies) available for deoxyuridine and pemetrexed

Article	Year
Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography. PloS one, 2013, Volume: 8, Issue:5 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxyuridine; Dideoxynucleosides; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Pemetrexed; Polymorphism, Genetic; Positron-Emission Tomography; Prognosis; Thymidylate Synthase; Time Factors; Tissue Distribution	2013
Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdU. Molecular cancer research : MCR, 2018, Volume: 16, Issue:2 Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyuridine; Drug Resistance, Neoplasm; Drug Synergism; Gene Knockdown Techniques; Gene Knockout Techniques; HCT116 Cells; Humans; Mutation; Neoplasms; Pemetrexed; RNA, Small Interfering; Tumor Suppressor Protein p53; Uracil-DNA Glycosidase	2018

Article

Year

Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.

PloS one, 2013, Volume: 8, Issue:5

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxyuridine; Dideoxynucleosides; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Pemetrexed; Polymorphism, Genetic; Positron-Emission Tomography; Prognosis; Thymidylate Synthase; Time Factors; Tissue Distribution

2013

Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdU.

Molecular cancer research : MCR, 2018, Volume: 16, Issue:2

Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyuridine; Drug Resistance, Neoplasm; Drug Synergism; Gene Knockdown Techniques; Gene Knockout Techniques; HCT116 Cells; Humans; Mutation; Neoplasms; Pemetrexed; RNA, Small Interfering; Tumor Suppressor Protein p53; Uracil-DNA Glycosidase

2018